|
Piecewise exponential hazard regression model for factors associated with death in cases aged 18–64 years with invasive pneumococcal infection |
|||||||||
| Death at 0–7 days |
Death at 8–28 days |
Death at 29–90 days |
|||||||
|
|
|
|
|||||||
| Factor |
Hazard ratio |
95%CIa |
P-value |
Hazard ratio |
95%CIa |
P-value |
Hazard ratio |
95%CIa |
P-value |
|
|
|||||||||
| Male sex |
0.9 |
0.6–1.2 |
0.5 |
1.6 |
1.3–2.0 |
< 0.001 |
1.6 |
1.3–2.0 |
< 0.001 |
| Age > 50 years |
1.3 |
1.1–1.7 |
< 0.05 |
1.3 |
1.1–1.7 |
< 0.05 |
2.8 |
2.2–3.5 |
< 0.001 |
| Meningitis |
1.2 |
0.7–2.3 |
0.7 |
3.2 |
2.0–5.0 |
< 0.001 |
0.7 |
0.4–1.2 |
0.3 |
| Alcohol-related diseases |
5.6 |
3.8–8.1 |
< 0.001 |
3.8 |
2.9–4.9 |
< 0.001 |
3.8 |
2.9–4.9 |
< 0.001 |
| Cardiac failure |
2.6 |
1.8–3.8 |
< 0.001 |
2.6 |
1.8–3.8 |
< 0.001 |
2.6 |
1.8–3.8 |
< 0.001 |
| Chronic renal failure |
1.6 |
0.5–5.2 |
0.4 |
1.6 |
0.5–5.2 |
0.4 |
1.6 |
0.5–5.2 |
0.4 |
| Chronic liver disease |
4.4 |
2.3–8.6 |
< 0.001 |
4.4 |
2.3–8.6 |
< 0.001 |
4.4 |
2.3–8.6 |
< 0.001 |
| HIV infection |
4.8 |
2.1–10.9 |
< 0.001 |
4.8 |
2.1–10.9 |
< 0.001 |
4.8 |
2.1–10.9 |
< 0.001 |
| Haematological malignancyb |
0.9 |
0.2–3.5 |
0.6 |
0.9 |
0.2–3.5 |
0.6 |
6.9 |
4.1–11.5 |
< 0.001 |
| Non-haematological malignancyb |
4.7 |
3.3–6.7 |
< 0.001 |
4.7 |
3.3–6.7 |
< 0.001 |
4.7 |
3.3–6.7 |
< 0.001 |
| Diabetes mellitus |
1.4 |
0.9–2.0 |
0.13 |
1.4 |
0.9–2.0 |
0.13 |
1.4 |
0.9–2.0 |
0.13 |
| Chronic pulmonary disease |
1.0 |
0.6–1.6 |
1.0 |
1.0 |
0.6–1.6 |
1.0 |
1.0 |
0.6–1.6 |
1.0 |
| Organ/bone marrow transplantation |
0.9 |
0.4–1.8 |
0.7 |
0.9 |
0.4–1.8 |
0.7 |
0.9 |
0.4–1.8 |
0.7 |
| Immunodeficiency/rheumatic diseases |
1.7 |
1.2–2.2 |
< 0.05 |
1.7 |
1.2–2.2 |
< 0.05 |
1.7 |
1.2–2.2 |
< 0.05 |
| Otherc medical underlying conditions |
1.7 |
1.3–2.2 |
< 0.001 |
1.7 |
1.3–2.2 |
< 0.001 |
1.7 |
1.3–2.2 |
< 0.001 |
| Healthy |
Ref.d |
Ref. |
Ref. |
||||||
|
aCI, confidence interval; b < 1 year since cancer diagnosis; cnon-PPV23 indication; dRef., reference | |||||||||
Klemets et al. BMC Infectious Diseases 2008 8:96 doi:10.1186/1471-2334-8-96 |
|||||||||